Advertisement

Hypercoagulability in ICU Patients With Coronavirus Disease 2019 With Respiratory Failure Results in Increased Prevalence of Venous Thromboembolic Disease

Published:September 13, 2020DOI:https://doi.org/10.1016/j.chest.2020.09.081
      Many studies indicate that severe coronavirus disease 2019 (COVID-19) infection is associated with a hypercoagulable state, as evidenced by pathologic findings from lung autopsies.
      • Xu Z.
      • Shi L.
      • Wang Y.
      • et al.
      Pathological findings of COVID-19 associated with acute respiratory distress syndrome.
      Procoagulant antiphospholipid antibodies have also been reported in patients with COVID-19.
      • Zhang Y.
      • Xiao M.
      • Zhang S.
      • et al.
      Coagulopathy and antiphospholipid antibodies in patients with Covid-19.
      We sought to determine the prevalence of DVT in patients with COVID-19 and ARDS within our ICUs.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to CHEST
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Xu Z.
        • Shi L.
        • Wang Y.
        • et al.
        Pathological findings of COVID-19 associated with acute respiratory distress syndrome.
        Lancet Respir Med. 2020; 8: 420-422
        • Zhang Y.
        • Xiao M.
        • Zhang S.
        • et al.
        Coagulopathy and antiphospholipid antibodies in patients with Covid-19.
        N Engl J Med. 2020; 382: e38
        • Kahn S.R.
        • Lim W.
        • Dunn A.S.
        • et al.
        Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
        Chest. 2012; 141: e195S-e226
        • Arabi Y.M.
        • Al-Hameed F.
        • Burns K.E.A.
        • et al.
        Adjunctive intermittent pneumatic compression for venous thromboprophylaxis.
        N Engl J Med. 2019; 380: 1305-1315
        • Cook D.
        • Meade M.
        • Guyatt G.
        • et al.
        • PROTECT Investigators for the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group
        Dalteparin versus unfractionated heparin in critically ill patients.
        N Engl J Med. 2011; 364: 1305-1314
        • Kaplan D.
        • Casper T.C.
        • Elliott C.G.
        • et al.
        VTE incidence and risk factors in patients with severe sepsis and septic shock.
        Chest. 2015; 148: 1224-1230
        • Avnon L.S.
        • Munteanu D.
        • Smoliakov A.
        • Jotkowitz A.
        • Barski L.
        Thromboembolic events in patients with severe pandemic influenza A/H1N1.
        Eur J Intern Med. 2015; 26: 596-598
        • Wang D.
        • Hu B.
        • Hu C.
        • et al.
        Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China.
        JAMA. 2020; 323: 1061-1069
        • Anderson Jr., F.A.
        • Spencer F.A.
        Risk factors for venous thromboembolism.
        Circulation. 2003; 107: I9-I16
        • Centers for Disease Control and Prevention (CDC)
        Intensive-care patients with severe novel influenza A (H1N1) virus infection—Michigan, June 2009.
        MMWR Morb Mortal Wkly Rep. 2009; 58: 749-752
        • Tang N.
        • Bai H.
        • Chen X.
        • Gong J.
        • Li D.
        • Sun Z.
        Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.
        J Thromb Haemost. 2020; 18: 1094-1099
        • Paranjpe I.
        • Fuster V.
        • Lala A.
        • et al.
        Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19.
        J Am Coll Cardiol. 2020; 76: 122-124
        • Obi A.T.
        • Tignanelli C.J.
        • Jacobs B.N.
        • et al.
        Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients.
        J Vasc Surg Venous Lymphat Disord. 2019; 7: 317-324